| abstract |
The present invention relates to the S enantiomer of a compound of formula (I), to a method for preparing such a compound, to its use in the treatment of clinical conditions, including lipid abnormalities (dyslipidemia) irrespective of their association with insulin resistance, and their therapeutic use Methods and pharmaceutical compositions containing the same are provided:n n n Formula In n n n n n n n In the above formula, R 1 is chloro, trifluoromethyl or trifluoromethoxy, R 2 is H or fluoro, and R 3 is a C 2-4 alkyl group. |